Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Stip

Showing results (161-170 of 278) with videos related to

Pageof 28
Sort By:
Schizophrenia Research|October 7, 2008
Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICSLaurent Lecardeur, Catherine Briand, Antoinette Prouteau, et al.
Schizophrenia Research|September 15, 2007
Does hyperpriming reveal impaired spreading of activation in schizophrenia?Laurent Lecardeur, Perrine Brazo, Sonia Dollfus, et al.
Schizophrenia Bulletin|January 24, 2012
The incidence and nature of cerebellar findings in schizophrenia: a quantitative review of fMRI literatureOvidiu Lungu, Marc Barakat, Samuel Laventure, et al.
Development and Psychopathology|September 19, 2024
Resting-state alterations in emotion salience and default-mode network connectivity in atypical trajectories of psychotic-like experiencesRoxane Assaf, Julien Ouellet, Josiane Bourque, et al.
Clinical Therapeutics|December 3, 2011
Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profileEmmanuel Stip, Simon Zhornitsky, Hoda Moteshafi, et al.
Schizophrenia Research|June 17, 2008
Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patientsEmmanuel Stip, Adham Mancini-Marïe, Cherine Fahim, et al.
Cognitive Neuropsychiatry|January 25, 2013
Clozapine and visuospatial processing in treatment-resistant schizophreniaJosiane Bourque, Nadia Lakis, Julie Champagne, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 5, 2017
Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective StudyDrigissa Ilies, Anne-Sophie Huet, Eric Lacourse, et al.
Schizophrenia Research|April 28, 2009
Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized studyLaurent Lecardeur, Emmanuel Stip, Michel Giguere, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 18, 2007
Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTABMarie-Noëlle Levaux, Stéphane Potvin, Amir Ali Sepehry, et al.
Pageof 28

Showing results (161-170 of 278) with videos related to

Sort By:
Pageof 28
Schizophrenia Research|October 7, 2008
Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICSLaurent Lecardeur, Catherine Briand, Antoinette Prouteau, et al.
Schizophrenia Research|September 15, 2007
Does hyperpriming reveal impaired spreading of activation in schizophrenia?Laurent Lecardeur, Perrine Brazo, Sonia Dollfus, et al.
Schizophrenia Bulletin|January 24, 2012
The incidence and nature of cerebellar findings in schizophrenia: a quantitative review of fMRI literatureOvidiu Lungu, Marc Barakat, Samuel Laventure, et al.
Development and Psychopathology|September 19, 2024
Resting-state alterations in emotion salience and default-mode network connectivity in atypical trajectories of psychotic-like experiencesRoxane Assaf, Julien Ouellet, Josiane Bourque, et al.
Clinical Therapeutics|December 3, 2011
Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profileEmmanuel Stip, Simon Zhornitsky, Hoda Moteshafi, et al.
Schizophrenia Research|June 17, 2008
Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patientsEmmanuel Stip, Adham Mancini-Marïe, Cherine Fahim, et al.
Cognitive Neuropsychiatry|January 25, 2013
Clozapine and visuospatial processing in treatment-resistant schizophreniaJosiane Bourque, Nadia Lakis, Julie Champagne, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 5, 2017
Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective StudyDrigissa Ilies, Anne-Sophie Huet, Eric Lacourse, et al.
Schizophrenia Research|April 28, 2009
Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized studyLaurent Lecardeur, Emmanuel Stip, Michel Giguere, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 18, 2007
Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTABMarie-Noëlle Levaux, Stéphane Potvin, Amir Ali Sepehry, et al.
Pageof 28